NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/27/2024
Back to search
Official data from USPTO
ICAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ICAN
ST13
US500000087003192Class
35, 36, 41, 42, 44, 45
Filing
87003192
Registration
5383250
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/27/2024
Trademark type
Word
Nice classes
35, 36, 41, 42, 44, 45
Filing date
04/15/2016
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2024
Last transaction
07/27/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2007-00-00
First use in commerce
2007-00-00
Drawing code
4
Owner type
99
Owner location
Phoenix, AZ
Examiner
RIRIE, VERNA BETH
Current location
FILE DESTROYED
Holders and representatives
Holders
I. N. (pessoa física)
Representatives
Susan Stone Rosenfield FENNEMORE CRAIG, P.C.
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Lobbying servicespromoting the interests of cancer patientscancer researcherscancer treatment providersothers involved with cancer researchdiagnosis and treatment; providing information in the field of patient-payor communications in which information regarding medical billing can be exchanged; providing information in the field of government affairs related to the expanded access to experimental cancer drugs for compassionate use; providing physician and medical specialist referrals to patients fighting chronic diseases and lethal diseases for assisting in the access to second opinions; providing information in the nature of discounts and rebates for cancer patients for diagnostic testsdrugs and medical devices
Class 36
Charitable fundraising to support providing educational services and information about preventionscreeningdiagnosis and treatment of cancercancer patient navigation servicescancer patient and clinical trials advocacy programsresearchdevelopment and regulatory approval of methodsdrugs and devices for preventionscreeningdiagnosis and treatment of cancerlobbying and legislation regarding cancer-related issuespatient-provider communicationspatient-payor communications; providing information concerning the patient's financial reimbursement from medical insurers and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer treatment; providing information regarding insurance coverage and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer patients for diagnostic testsdrugs and medical devices
Class 41
Co-sponsoring and providing educational conferencesboth live and via telephone conferencesseminarsclasses and workshops in the field of cancer-related issues and distribution of educational materials in connection therewith; on-line journalsblogs featuring information in the field of cancer-related issues; providing podcasts and non-downloadable videos in the field of cancer-related issues; providing on-line journalsblogs featuring cancer-related issues and postings in honor of patients and in memory of patients
Class 42
Providing information in the field of anti-cancer drug discovery and development; providing information in the field of clinical trials
Class 44
Providing information about preventionscreeningdiagnosis and treatment of cancer; providing a websitelinks to the websites of othersfeaturing information about preventionscreeningdiagnosis and treatment of cancer; providing information in the field of patient medical information where patients can inquire about medical issues and be directed to resources for medical information customized to their need for information about their condition; providing information in the field of cancer preventionscreeningdiagnosis and treatment; providing information in the field of cancer treatment for the benefit of patients and patients' families; providing information in the field of communications between patients and health care providers in which patient medical information can be exchanged; providing information in the field of patient access to diagnostic testsdrugs and medical devices provided by health care facilities; providing information in the field of medicinepersonalized medicinepathologyoncologyinterventional radiologyradiogenomicsanesthesiology; providing information in the field of complementary and alternative medicine for use in the prevention and treatment of cancer; providing access to medical specialists for second opinions for patients fighting chronic diseases and lethal diseases
Class 45
Providing patient advocacy and patient advocate services in the field of cancer treatment; providing cancer patient advocacy programs; providing advocacy services to potential participants and participants in clinical trials; providing information in the field of personal emotional support of cancer patients and patients' families; providing information in the field of regulatory affairs compliance relating to the approval of anticancer compounds in the U.S. and abroad
Publications
History of USPTO decisions and trademark events.
27 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/27/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/12/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
ALIE
ASSIGNED TO LIE
10/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/07/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/19/2017
GNFR
FINAL REFUSAL E-MAILED
03/19/2017
CNFR
FINAL REFUSAL WRITTEN
03/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2016
GNRT
NON-FINAL ACTION E-MAILED
08/03/2016
CNRT
NON-FINAL ACTION WRITTEN
08/03/2016
DOCK
ASSIGNED TO EXAMINER
07/29/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
04/21/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2016
NWAP
NEW APPLICATION ENTERED
04/19/2016
Continuous trademark protection
Get notified about every new filing that threatens ICAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.